Publication | Open Access

Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy

UrologyPerineural InvasionGenitourinary CancerMedicinePten ExpressionRadical ProstatectomySecondary TherapiesTumor SuppressorProstatic DiseaseOncologyCell BiologyTumor Biology